文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

早期长时间俯卧位对无创通气COVID-19相关中重度低氧性呼吸衰竭患者的临床结局与治疗反应机制:PRO-NIV研究

Early prolonged prone position in noninvasively ventilated patients with SARS-CoV-2-related moderate-to-severe hypoxemic respiratory failure: clinical outcomes and mechanisms for treatment response in the PRO-NIV study.
PubMed 文献 · Crit Care · 2022-04-29
一句话结论早期长时间俯卧位可安全降低无创通气COVID-19中重度低氧性呼吸衰竭患者的28天NIV失败、插管和死亡风险,且第1天CO2反应是预测结局的指标。

PRO-NIV研究为对照非随机试验,纳入81例接受早期俯卧位+无创通气的COVID-19肺炎合并中重度急性低氧性呼吸衰竭(paO2/FiO2<200)患者,与162例倾向性评分匹配的仰卧位无创通气对照组比较。结果显示俯卧位组28天NIV失败17% vs 43%(HR=0.32),插管11% vs 30%(HR=0.31),死亡12% vs 36%(HR=0.27),不良事件罕见且分布均衡。俯卧位还与氧合和死腔指数改善、背外侧肺区域复张、炎症标志物和D-二聚体更早下降相关,第1天CO2反应优于O2反应预测临床结局。

要点

  • 早期长时间俯卧位+无创通气使28天NIV失败率从43%降至17%(HR=0.32, 95%CI 0.21-0.50, p<0.0001),插管率从30%降至11%(HR=0.31, 95%CI 0.18-0.55, p=0.0012),死亡率从36%降至12%(HR=0.27, 95%CI 0.17-0.44, p<0.0001)。
  • 俯卧位效应在入院时paO2/FiO2<100和100-199两个亚组中均显著。
  • 俯卧位治疗组不良事件罕见且与对照组分布均衡。
  • 第1天CO2反应较O2反应更能预测肺超声变化、NIV失败、插管和死亡。
  • 俯卧位通过改善背外侧肺区域复张降低整体肺超声严重程度指数,并改善死腔指数和氧合。

适用人群与场景

  • COVID-19肺炎合并中重度急性低氧性呼吸衰竭(paO2/FiO2<200)接受无创通气的患者。
  • 研究在HUMANITAS Gradenigo亚重症监护病房进行。
  • 纳入连续前瞻性入组的81例早期俯卧位+无创通气患者(2020年12月至2021年5月)和162例年龄、死亡风险、病情严重程度及入院paO2/FiO2匹配的常规仰卧位无创通气患者(2020年4月至2020年12月)。
  • 排除标准未在摘要中报告。

诊断标准与关键阈值

  • 中重度急性低氧性呼吸衰竭定义为paO2/FiO2比值<200。

处置流程与药物剂量

  • 早期长时间俯卧位联合无创通气,具体俯卧位时长、频次和疗程未在摘要中报告。
  • 对照组采用常规仰卧位无创通气。

研究设计与关键结果

  • 研究类型:对照非随机试验,纳入81例俯卧位+无创通气患者和162例倾向性评分匹配的仰卧位无创通气对照,比较28天NIV失败、插管和死亡。
  • 主要终点:NIV失败在俯卧位组14例(17%)vs 对照组70例(43%),HR=0.32,95%CI 0.21-0.50,p<0.0001。
  • 插管:俯卧位组8例(11%)vs 对照组44例(30%),HR=0.31,95%CI 0.18-0.55,p=0.0012。
  • 死亡:俯卧位组10例(12%)vs 对照组59例(36%),HR=0.27,95%CI 0.17-0.44,p<0.0001。
  • 亚组分析:效应在入院paO2/FiO2<100或100-199的严重程度类别中均保持显著。
  • 不良事件罕见且分布均衡。
  • 生理机制:俯卧位治疗与氧合和死腔指数改善、整体肺超声严重程度指数降低(主要因背外侧肺区域复张增强)、炎症标志物和D-二聚体更早下降相关。
  • 多因素分析:第1天CO2反应预测肺超声变化、NIV失败、插管和死亡优于O2反应。

证据类型、等级与局限

  • 证据类型:对照非随机试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期长时间俯卧位安全,且与无创通气COVID-19相关中重度低氧性呼吸衰竭患者较低的NIV失败、插管和死亡发生率相关。
  • 作者认为,早期死腔减少和背外侧肺区域复张可预测本研究人群的临床结局。
  • 第1天CO2反应可能有助于预测俯卧位治疗反应和临床结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Whether prone position (PP) improves clinical outcomes in COVID-19 pneumonia treated with noninvasive ventilation (NIV) is unknown. We evaluated the effect of early PP on 28-day NIV failure, intubation and death in noninvasively ventilated patients with moderate-to-severe acute hypoxemic respiratory failure due to COVID-19 pneumonia and explored physiological mechanisms underlying treatment response.

METHODS: In this controlled non-randomized trial, 81 consecutive prospectively enrolled patients with COVID-19 pneumonia and moderate-to-severe (paO2/FiO2 ratio < 200) acute hypoxemic respiratory failure treated with early PP + NIV during Dec 2020-May 2021were compared with 162 consecutive patients with COVID-19 pneumonia matched for age, mortality risk, severity of illness and paO2/FiO2 ratio at admission, treated with conventional (supine) NIV during Apr 2020-Dec 2020 at HUMANITAS Gradenigo Subintensive Care Unit, after propensity score adjustment for multiple baseline and treatment-related variables to limit confounding. Lung ultrasonography (LUS) was performed at baseline and at day 5. Ventilatory parameters, physiological dead space indices (DSIs) and circulating inflammatory and procoagulative biomarkers were monitored during the initial 7 days.

RESULTS: In the intention-to-treat analysis. NIV failure occurred in 14 (17%) of PP patients versus 70 (43%) of controls [HR = 0.32, 95% CI 0.21-0.50; p < 0.0001]; intubation in 8 (11%) of PP patients versus 44 (30%) of controls [HR = 0.31, 95% CI 0.18-0.55; p = 0.0012], death in 10 (12%) of PP patients versus 59 (36%) of controls [HR = 0.27, 95% CI 0.17-0.44; p < 0.0001]. The effect remained significant within different categories of severity of hypoxemia (paO2/FiO2 < 100 or paO2/FiO2 100-199 at admission). Adverse events were rare and evenly distributed. Compared with controls, PP therapy was associated with improved oxygenation and DSIs, reduced global LUS severity indices largely through enhanced reaeration of dorso-lateral lung regions, and an earlier decline in inflammatory markers and D-dimer. In multivariate analysis, day 1 CO2 response outperformed O2 response as a predictor of LUS changes, NIV failure, intubation and death.

CONCLUSION: Early prolonged PP is safe and is associated with lower NIV failure, intubation and death rates in noninvasively ventilated patients with COVID-19-related moderate-to-severe hypoxemic respiratory failure. Early dead space reduction and reaeration of dorso-lateral lung regions predicted clinical outcomes in our study population.

CLINICAL TRIAL REGISTRATION: ISRCTN23016116 . Retrospectively registered on May 1, 2021.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Musso G, Taliano C, Molinaro F, et al. Early prolonged prone position in noninvasively ventilated patients with SARS-CoV-2-related moderate-to-severe hypoxemic respiratory failure: clinical outcomes and mechanisms for treatment response in the PRO-NIV study. Crit Care. 2022. PMID: 35488356. doi:10.1186/s13054-022-03937-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。